---
pmid: '17560333'
title: Role of the polycomb repressive complex 2 in acute promyelocytic leukemia.
authors:
- Villa R
- Pasini D
- Gutierrez A
- Morey L
- Occhionorelli M
- Viré E
- Nomdedeu JF
- Jenuwein T
- Pelicci PG
- Minucci S
- Fuks F
- Helin K
- Di Croce L
journal: Cancer Cell
year: '2007'
full_text_available: false
doi: 10.1016/j.ccr.2007.04.009
---

# Role of the polycomb repressive complex 2 in acute promyelocytic leukemia.
**Authors:** Villa R, Pasini D, Gutierrez A, Morey L, Occhionorelli M, Viré E, Nomdedeu JF, Jenuwein T, Pelicci PG, Minucci S, Fuks F, Helin K, Di Croce L
**Journal:** Cancer Cell (2007)
**DOI:** [10.1016/j.ccr.2007.04.009](https://doi.org/10.1016/j.ccr.2007.04.009)

## Abstract

1. Cancer Cell. 2007 Jun;11(6):513-25. doi: 10.1016/j.ccr.2007.04.009.

Role of the polycomb repressive complex 2 in acute promyelocytic leukemia.

Villa R(1), Pasini D, Gutierrez A, Morey L, Occhionorelli M, Viré E, Nomdedeu 
JF, Jenuwein T, Pelicci PG, Minucci S, Fuks F, Helin K, Di Croce L.

Author information:
(1)Centre de Regulacio Genomica, c/ Dr. Aiguader 88, 08003 Barcelona, Spain.

Comment in
    Cancer Cell. 2007 Jun;11(6):475-8. doi: 10.1016/j.ccr.2007.05.005.

Epigenetic changes are common alterations in cancer cells. Here, we have 
investigated the role of Polycomb group proteins in the establishment and 
maintenance of the aberrant silencing of tumor suppressor genes during 
transformation induced by the leukemia-associated PML-RARalpha fusion protein. 
We show that in leukemic cells knockdown of SUZ12, a key component of Polycomb 
repressive complex 2 (PRC2), reverts not only histone modification but also 
induces DNA demethylation of PML-RARalpha target genes. This results in promoter 
reactivation and granulocytic differentiation. Importantly, the epigenetic 
alterations caused by PML-RARalpha can be reverted by retinoic acid treatment of 
primary blasts from leukemic patients. Our results demonstrate that the direct 
targeting of Polycomb group proteins by an oncogene plays a key role during 
carcinogenesis.

DOI: 10.1016/j.ccr.2007.04.009
PMID: 17560333 [Indexed for MEDLINE]
